Antimutagenic and anticarcinogenic effects of wheat bran in vivo

Genetics and Molecular Research

Volumn 12, Issue 2, 2013, Pages 1646-1659

  Pesarinil, J R ^b,c   Zaninetti, P T ^a   Mauro, M O ^a,b,c   Carreira, C M ^d   Dichi, J B ^d   Ribeiro, L R ^b   Mantovani, M S ^d   Oliveira, R J ^c  

^a Centro Universitário Filadélfia   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^d STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Chemoprevention; Functional food; Triticum aestivum; Wheat bran

Indexed keywords

DNA;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RISK; CELL CYCLE; CELL PROLIFERATION; COLON CANCER; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; GENOTOXICITY; IN VIVO STUDY; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; TRITICUM AESTIVUM; WHEAT BRAN;

EID: 84878104013     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.May.14.5     Document Type: Article

References (40)

1. Alabaster O, Tang Z, Frost A and Shivapurkar N (1995). Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 16: 127-132.
2. Bailar JC III and Smith EM (1986). Progress against cancer? N. Engl. J. Med. 314: 1226-1232.
3. Barbolt TA and Abraham R (1978). The effect of bran on dimethylhydrazine-induced colon carcinogenesis in the rat. Proc. Soc. Exp. Biol. Med. 157: 656-659.
4. Bird RP (1987). Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37: 147-151.
5. Blaut M (2002). Relationship of prebiotics and food to intestinal microflora. Eur. J. Nutr. 41 (Suppl 1): I-11-I-16.
6. Bolognani F, Rumney CJ, Pool-Zobel BL and Rowland IR (2001). Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur. J. Nutr. 40: 293-300.
7. Cummings JH (1993). Handbook of Dietary Fiber in Human Nutrition. In: The Effect of Dietary Fiber on Fecal Weight and Composition (Spiller GA,ed.)CRC Press, Boca Raton, 263-349.
8. De Flora S (1998). Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402: 151-158.
9. Doll R and Peto R (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66: 1191-1308.
10. Ferguson LR (1994). Antimutagens as cancer chemopreventive agents in the diet. Mutat. Res. 307: 395-410.
11. Ferlay J, Shin HR, Bray F, Forman D, et al. (2010). GLOBOCAN v1.2 - Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 10/2010. Available at [http://globocan.iarc.fr]. Accessed August 13, 2012.
12. Flagg EW, Coates RJ and Greenberg RS (1995). Epidemiologic studies of antioxidants and cancer in humans. J. Am. Coll. Nutr. 14: 419-427.
13. Graf E and Eaton JW (1993). Suppression of colonic cancer by dietary phytic acid. Nutr. Cancer 19: 11-19.
14. Greenwald P and Cullen JW (1985). The new emphasis in cancer control. J. Natl. Cancer Inst. 74: 543-551.
15. Hayashi M, Morita T, Kodama Y, Sofuni T, et al. (1990). The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 245: 245-249.
16. Hollmann J and Lindhauer MG (2005). Pilot-scale isolation of glucuronoarabinoxylans from wheat bran. Carbohydrate Polymers 59: 225-230.
17. Ishii PL, Prado CK, Mauro MO, Carreira CM, et al. (2011). Evaluation of Agaricus blazei in vivo for antigenotoxic, anticarcinogenic, phagocytic and immunomodulatory activities. Regul. Toxicol. Pharmacol. 59: 412-422.
18. Jacobs ET, Lanza E, Alberts DS, Hsu CH, et al. (2006). Fiber, sex, and colorectal adenoma: results of a pooled analysis. Am. J. Clin. Nutr. 83: 343-349.
19. Jenab M and Thompson LU (1998). The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 19: 1087-1092.
20. Kada T (1981). Environmental desmutagens and antidesmutagens. Indian J. Biochem. Biophys. 18: 5-6.
21. Kada T and Shimoi K (1987). Desmutagens and bio-antimutagens - their modes of action. Bioessays 7: 113-116.
22. Kobayashi H, Sugiyama C, Morikawa Y, Hayashi M, et al. (1995). A comparison between manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis assay. MMS Comm. 3: 103-115.
23. Krutovskikh VA and Turosov VS (1994). Pathology of Tumors in Laboratory Animals. In: Tumors of Intestines (Turosov VS and Mohr U, eds.). Yarc, Lyon, 195-211.
24. Lamont JT and O'gorman TA (1978). Experimental colon cancer. Gastroenterology 75: 1157-1169.
25. Li SC, Chen CM, Lin SH, Chiang W, et al. (2011). Effects of adlay bran and its ethanolic extract and residue on preneoplastic lesions of the colon in rats. J. Sci. Food Agric. 91: 547-552.
26. Maes C, Vangeneugden B and Delcoour JA (2004). Relative activity of two endoxylanases towards water-unextractable arabinoxylans in wheat bran. J. Cereal Sci. 39: 181-186.
27. Marlett JA (1993). Oat bran. In: Comparisons of Dietary Fiber and Selected Nutrient Compositions of Oat and Other Grain Fractions (Wood P, ed.). American Association of Cereal Chemists, St. Paul, 49-82.
28. Oliveira RJ, Baise E, Mauro MD, Pesarini JR, et al. (2009). Evaluation of chemopreventive activity of glutamine by the comet and the micronucleus assay in mice's peripheral blood. Environ. Toxicol. Pharmacol. 28: 120-124.
29. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, et al. (1996). Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 275: 447-451.
30. Roberfroid MB (1991). Dietary modulation of experimental neoplastic development: role of fat and fiber content and calorie intake. Mutat. Res. 259: 351-362.
31. Roberfroid MB (2005). Introducing inulin-type fructans. Br. J. Nutr. 93 (Suppl 1): S13-S25.
32. Rodrigues MA, Silva LA, Salvadori DM, De Camargo JL, et al. (2002). Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J. Med. Biol. Res. 35: 351-355.
33. Sang S, Ju J, Lambert JD, Lin Y, et al. (2006). Wheat bran oil and its fractions inhibit human colon cancer cell growth and intestinal tumorigenesis in Apc(min/+) mice. J. Agric. Food Chem. 54: 9792-9797.
34. Shamsuddin AM, Vucenik I and Cole KE (1997). IP6: a novel anti-cancer agent. Life Sci. 61: 343-354.
35. Tian Y and Song Y (2006). Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line. World J. Gastroenterol. 12: 4137-4142.
36. Tice RR, Agurell E, Anderson D, Burlinson B, et al. (2000). Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35: 206-221.
37. Topping DL and Clifton PM (2001). Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81: 1031-1064.
38. Vucenik I and Shamsuddin AM (2003). Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J. Nutr. 133: 3778S-3784S.
39. Watanabe K, Reddy BS, Weisburger JH and Kritchevsky D (1979). Effect of dietary alfalfa, pectin, and wheat bran on azoxymethane-or methylnitrosourea-induced colon carcinogenesis in F344 rats. J. Natl. Cancer Inst. 63: 141-145.
40. Wilson RB, Hutcheson DP and Wideman L (1977). Dimethylhydrazine-induced colon tumors in rats fed diets containing beef fat or corn oil with and without wheat bran. Am. J. Clin. Nutr. 30: 176-181.